HI
TCRT icon

Harbour Investments’s Alaunos Therapeutics TCRT Stock Holding History

Harbour Investments’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46
Closed -$148 – 3575
2024
Q3 		$148 Buy
+46
New +$165 ﹤0.01% 3294
2024
Q2 		– Sell
-47
Closed -$843 – 3369
2024
Q1 		$843 Buy
+47
New +$939 ﹤0.01% 2963
2023
Q4 		– Sell
-47
Closed -$923 – 3198
2023
Q3 		$923 Hold
47
– – ﹤0.01% 2719
2023
Q2 		$3.57K Hold
47
– – ﹤0.01% 2377
2023
Q1 		$4.41K Hold
47
– – ﹤0.01% 2318
2022
Q4 		$4.54K Buy
+47
New +$6.81K ﹤0.01% 2255

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Harbour Investments's TCRT Position: Q4 2024 in Review

Harbour Investments sold out of Alaunos Therapeutics (TCRT) in Q4 2024, closing a stake of 46 shares — an estimated $148 sold.

Harbour Investments first reported a position in TCRT in Q4 2022 and held it in 6 quarters. The position peaked at $4.54K in Q4 2022. 30 funds tracked by Wall St. Rank hold TCRT as of Q4 2024.

  • Harbour Investments reported no remaining Alaunos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 46 Alaunos Therapeutics shares in Q4 2024, an estimated $148.
  • Harbour Investments first reported a position in Alaunos Therapeutics in Q4 2022 and held it in 6 quarters.
  • Harbour Investments's Alaunos Therapeutics position peaked at $4.54K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.